← Leaderboards
Andrea Vambutas
Long Island Jewish Medical Center
$2,648,730
Attributed
$2,648,730
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $498.8K · FY2009–15$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,648,730 · 5
By mechanism
R33$1,464,310 · 1
R21$705,500 · 2
K23$241,920 · 1
R03$237,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Long Island Jewish Medical Center
Same institution · by research overlap
- Bettie M. Steinberg$8,670,531
Others in their field
Top investigators on “Immune”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmuneInner Ear DiseasesPreventMediatingSensorineural Hearing LossAutologousPeripheral BloodInterleukin-1Hearing ImpairmentPerilymphReceptorResponseHearingSignal TransductionAutoimmune ProcessInterleukin-1 Receptor Type IiInflammatoryImmunoprecipitationVirus ProteinWestern BlottingsHuman PapillomavirusHuman TissueImmunocytochemistryAdrenal Cortex Hormones
Grant awards (12)
A phase I clinical trial of Anakinra for Steroid-Resistant AIED$101
R33 · FY2015 · DC · contact PI
A phase I clinical trial of Anakinra for Steroid-Resistant AIED$498,834
R33 · FY2014 · DC · contact PI
A phase I clinical trial of Anakinra for Steroid-Resistant AIED$473,810
R33 · FY2013 · DC · contact PI
A phase I clinical trial of Anakinra for Steroid-Resistant AIED$491,565
R33 · FY2012 · DC · contact PI
A phase I clinical trial of Anakinra for Steroid-Resistant AIED$249,000
R21 · FY2011 · DC · contact PI
A Decoy Receptor as a Novel Biomarker for Autoimmune Inner Ear Disease$166,000
R21 · FY2010 · DC · contact PI
A Decoy Receptor as a Novel Biomarker for Autoimmune Inner Ear Disease$290,500
R21 · FY2009 · DC · contact PI
TAP-1/E7 INTERACTION: ROLE IN RESPIRATORY PAPILLOMAS$79,000
R03 · FY2004 · DC
TAP-1/E7 INTERACTION: ROLE IN RESPIRATORY PAPILLOMAS$79,000
R03 · FY2003 · DC
TAP-1/E7 INTERACTION: ROLE IN RESPIRATORY PAPILLOMAS$79,000
R03 · FY2002 · DC
REGULATION OF TAP-1 AND MHC-I IN RESPIRATORY PAPILLOMAS$120,960
K23 · FY2001 · DC
REGULATION OF TAP-1 AND MHC-I IN RESPIRATORY PAPILLOMAS$120,960
K23 · FY2000 · DC